Nicholas C Yoder
3PUBLICATIONS
32CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (3)
Sort by Publication Date:
|May 05, 2022
Preclinical Evaluation of IMGC936, a Next-Generation Maytansinoid-based Antibody-drug Conjugate Targeting ADAM9-expressing Tumors.Juniper A Scribner, Stuart W Hicks, Kerstin W Sinkevicius
|Nov 21, 2019
Site-Specific Conjugation of the Indolinobenzodiazepine DGN549 to Antibodies Affords Antibody-Drug Conjugates with an Improved Therapeutic Index as Compared with Lysine Conjugation.Chen Bai, Emily E Reid, Alan Wilhelm
|Jul 10, 2019
A Case Study Comparing Heterogeneous Lysine- and Site-Specific Cysteine-Conjugated Maytansinoid Antibody-Drug Conjugates (ADCs) Illustrates the Benefits of Lysine Conjugation.Nicholas C Yoder, Chen Bai, Daniel Tavares
Pageof 1
Frequent Collaborators
1 joint publications
Wayne C Widdison
1 joint publications
Michael L Miller
1 joint publications
Juniper A Scribner
1 joint publications
Stuart W Hicks
1 joint publications
Kerstin W Sinkevicius
1 joint publications
Gundo Diedrich
1 joint publications
Jennifer G Brown
1 joint publications
Jacquelynn Lucas
1 joint publications
Megan E Fuller
1 joint publications
Thomas Son
